Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Recruiting
Observational Study
High Risk Pregnancy
Congenital Heart Disease
Fetal Hydrops
Twin Monochorionic Monoamniotic Placenta
Gastroschisis
Fetal Demise
Stillbirth
Fetal Arrhythmia
Long QT Syndrome
Intrauterine Fetal Death
Sudden Infant Death
Pregnancy Loss
Twin Twin Transfusion Syndrome
Birth Defect
Fetal Cardiac Anomaly
Fetal Cardiac Disorder
Fetal Death
Brugada Syndrome
Fetal Tachycardia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Medical College of Wisconsin · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) used thus far to successfully evaluate fetal arrhythmias, in order to discover potential hidden elect…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Current pregnancy complicated by one of the five diagnostic categories
* prior unexplained Stillbirth at/after 20 weeks gestation
* fetal major congenital heart defect
* fetal hydrops
* fetal gastroschisis
* monochorionic twin pregnancy
* Subject must be 18 years of…
Contacts